All-trans retinoic acid regulates CXCL16/SR-PSOX expression

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Retinoids are known to modulate inflammatory responses.
• CXCL16/SR-PSOX is a novel protein with dual chemokine and scavenger receptor functions.
• Understanding the regulation of CXCL16/SR-PSOX is crucial for inflammatory disease research.

Purpose of the Study:

• To investigate the effects of all-trans retinoic acid (atRA) on CXCL16/SR-PSOX expression.
• To determine the cell-specific nature of atRA's influence on CXCL16/SR-PSOX.
• To elucidate the receptor-mediated mechanisms involved in retinoid signaling.

Main Methods:

• Real-time PCR was used to quantify CXCL16/SR-PSOX mRNA expression.
• Enzyme-linked immunosorbent assay (ELISA) measured CXCL16 protein release.
• Experiments utilized THP-1 cells, endothelial cells, and smooth muscle cells.
• Retinoic acid receptor (RAR) antagonists and agonists were employed to study receptor mediation.

Main Results:

• atRA significantly increased CXCL16/SR-PSOX mRNA and protein expression in THP-1 and endothelial cells.
• The effect in THP-1 cells was mediated by retinoic acid receptors (RARs), with both RAR-alpha and RAR-gamma agonists showing activity.
• In smooth muscle cells, only mRNA levels of CXCL16/SR-PSOX were upregulated after prolonged treatment, with no change in protein expression.

Conclusions:

• Retinoid signaling, specifically through atRA, can modulate inflammatory responses by regulating CXCL16/SR-PSOX expression.
• The effect of atRA on CXCL16/SR-PSOX is cell-specific, impacting different cell types to varying degrees.
• These findings highlight a potential therapeutic pathway involving retinoids for inflammatory conditions.